A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
Top Cited Papers
- 28 February 2007
- journal article
- review article
- Published by Elsevier BV in Gastroenterology
- Vol. 132 (2), 763-786
- https://doi.org/10.1053/j.gastro.2006.12.038
Abstract
No abstract availableThis publication has 96 references indexed in Scilit:
- Infliximab for acute, not steroid-refractory ulcerative colitisEuropean Journal of Gastroenterology & Hepatology, 2004
- Patchiness of mucosal inflammation in treated ulcerative colitis: A prospective studyGastrointestinal Endoscopy, 1995
- Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitisDigestive Diseases and Sciences, 1995
- Olsalazine in maintenance of clinical remission in patients with ulcerative colitisDigestive Diseases and Sciences, 1993
- Clinical patterns, natural history, and progression of ulcerative colitisDigestive Diseases and Sciences, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Health status and health care use in persons with inflammatory bowel diseaseDigestive Diseases and Sciences, 1991
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisThe New England Journal of Medicine, 1987
- Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using99mTc-labeled 5-ASA suppositoriesDigestive Diseases and Sciences, 1987
- Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitisDigestive Diseases and Sciences, 1982